EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Oncolytic virus preclinical toxicology studies

Agnija Rasa iD, Pēteris Alberts iD

Journal of Applied Toxicology · 2023-05 · 43 (5) · 620-648

DOI: 10.1002/jat.4408 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Applied Toxicology, online erschienen am 07.11.2022. Verfasst von Agnija Rasa und 1 weiteren Autor:innen. Beteiligte Einrichtung: R&D, Rigvir, Riga, Latvia. Hauptthemen laut MEDLINE: Oncolytic Viruses, Oncolytic Virotherapy, Melanoma, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 123 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the ever‐emerging concerns of patient safety during medical care, the search for treatments as safe as possible is a priority, especially when focusing on cancer treatment of which therapies often go hand in hand with severe side effects. Oncolytic virotherapy is an emerging treatment for cancer that is promising in both safety and efficacy. Many currently ongoing clinical trials demonstrate the growing interest in this field. To conduct clinical trials, preclinical studies are mandatory; however, there are not many reviews of toxicology studies on oncolytic virus therapies. This article summarizes the preclinical toxicology studies of the most well studied oncolytic viruses, including Oncorine, Talimogene laherparepvec, Cavatak, ONYX‐015, teserpaturev and Rigvir, a non‐pathogenic ECHO‐7 virus. It is concluded that oncolytic viruses have been shown to have low toxicity and high tolerability in preclinical toxicology studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncolytic VirusesOncolytic VirotherapyMelanomaDrug-Related Side Effects and Adverse ReactionsHumansImmunotherapy

Stichwörter der Autor:innen

ECHO-7 virusRigvirmelanomaoncolytic virusvirotherapy

Autor:innen und Institutionen

  • R&D, Rigvir, Riga, Latvia.

ORCID-Profile: Agnija Rasa, Pēteris Alberts

Zitieren

APA

Rasa, A., & Alberts, P. (2023). Oncolytic virus preclinical toxicology studies. Journal of Applied Toxicology, 43(5), 620-648. https://doi.org/10.1002/jat.4408

Vancouver

Rasa A, Alberts P. Oncolytic virus preclinical toxicology studies. Journal of Applied Toxicology. 2023;43(5):620-648. doi:10.1002/jat.4408

BibTeX
@article{Rasa2023,
  author = {Rasa, Agnija and Alberts, Pēteris},
  title = {Oncolytic virus preclinical toxicology studies},
  journal = {Journal of Applied Toxicology},
  year = {2023},
  volume = {43},
  number = {5},
  pages = {620--648},
  doi = {10.1002/jat.4408}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche